Human CD40LG (Cd40 Ligand) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-00500P
SDS-PAGE analysis of Human CD40LG (Cd40 Ligand) - Recombinant Protein, CAT# BLT-00500P, showing >90% purity under 15% SDS-PAGE (Reduced)
Human CD40LG (Cd40 Ligand) - Recombinant Protein
Beta LifeScience
SKU/CAT #: BLT-00500P
Regular price
$59500
$595.00
Sale price$44500
$445.00Save $150
/
Quantity Pricing
| Pack Size | Price (USD) |
|---|---|
| 500 µg | $1,030 (Fall Promotion) |
| 1 mg | $1,870 (Fall Promotion) |
For direct online orders, quantity pricing will be displayed in cart when you add 5x100ug or 10x100ug
Submit an inquiry or email inquiry@betalifesci.com for a customization request or bulk order quote.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Cluster Of Differentiation 40 Ligand (CD40L/CD40LG) Protein |
| Product Overview | This recombinant human Cluster Of Differentiation 40 Ligand (CD40L/CD40LG) protein includes amino acids 1-261aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
| Target Uniprot Id | P29965 |
| Recommended Name | CD40 ligand |
| Gene Name | CD40LG |
| Synonyms | CD40 ligand, CD154, CD40L, gp39; hCD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP |
| Species | Human |
| Predicted Molecular Mass | 60 kDa |
| Expression System | E.coli |
| Expression Range | 1-261aa |
| Tag | N-6His |
| Purity | >90% |
| Formulation | Lyophilized |
| Buffer | Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
| Storage Condition | 1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
| Reconstitution Instruction | Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
| Applications | Positive Control; Immunogen; SDS-PAGE; WB |
| Research Area | Cancer, Immunology, Cardiovascular |
| Target Function | Cytokine that acts as a ligand to CD40/TNFRSF5. Costimulates T-cell proliferation and cytokine production. Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation. Induces the activation of NF-kappa-B. Induces the activation of kinases MAPK8 and PAK2 in T-cells. Induces tyrosine phosphorylation of isoform 3 of CD28. Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4. Involved in immunoglobulin class switching.; Acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling. |
| Subcellular Location | Cell membrane; Single-pass type II membrane protein. Cell surface.; [CD40 ligand, soluble form]: Secreted. |
| Protein Family | Tumor necrosis factor family |
| Associated Diseases | Immunodeficiency with hyper-IgM, type 1 (HIGM1) |
| Tissue Specificity | Specifically expressed on activated CD4+ T-lymphocytes. |
